Search

everythinglearnresearchcommunity

for

Search:↓

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

The woman was diagnosed with lichen sclerosus, a rare skin condition, after initial misdiagnosis and ineffective treatments.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

The congress highlighted concerns about the effectiveness of over-the-counter nail treatments, the link between hair loss and daily care products, and the safety of skin treatments during COVID-19.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Turkish pregnant women commonly experienced skin issues like itching and acne, and doctors mainly used topical treatments due to safety concerns during pregnancy.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Immune cells affect hair growth and could lead to new hair loss treatments.

Advancements in dermatology are improving diagnosis, treatment options, and patient care.

The guideline recommends using specific drugs and surgery together for treating hidradenitis suppurativa effectively.

HS needs personalized treatment plans and more research.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Andrographolide-loaded topical nanocarriers are a safe and effective treatment for psoriasis.

Galea fixation is a safe and effective way to remove bald scalp with minimal scarring and reduced stretch-back.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Early genetic testing and new therapies like secukinumab are crucial for managing Netherton syndrome effectively.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

The document concludes that there have been significant advances in the treatment and diagnosis of various skin conditions.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Botulinum toxin type A injections may help treat hidradenitis suppurativa.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.